MiMedx MDXG 深 滬
已收盤 11-06 16:00:00 美东时间
3.31
+0.030
+0.91%
華盛通- 最 高3.39
- 今 開3.25
- 成交量 110.69万股
- 最 低 3.225
- 昨 收 3.28
- 總市值 4.83亿
- 52周最高 7.51
- 市盈率 靜 10.20
- 換手率 0.76%
- 52周最低 3.025
- 委 比 -25.65%
- 總股本 1.46亿
- 歷史最高 18.25
- 量 比 0.51
- 振 幅 5.03%
- 歷史最低 0.83
- 每 手 1
- 風險率 1.17%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多MIMEDX to Participate in Upcoming Investor Conferences
MiMedx Group announced that its senior management will participate in two investor conferences: the Canaccord MedTech, Diagnostics and Digital Health & Services Forum in New York on November 11, 2026, and the Craig-Hallum 17th Annual Alpha Select Conference in New York on November 17, 2026. The company, a leader in wound care solutions, invites investors to contact Canaccord or Craig-Hallum representatives for meetings. MiMedx aims to be the lead...
11-06 13:00
MiMedx Group Inc.收跌15.46%，成交额880.09万美元
11月3日，MiMedx Group Inc.（MDXG）收跌15.46%，报3.28美元，成交额880.09万美元，市值4.79亿美元。 行情数据 • 开盘价...
11-03 07:06
MiMedx Group Q3 2026 Earnings Call Transcript
MiMedx Group (NASDAQ:MDXG) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.c...
10-29 05:17
MiMedx Group Lowers FY2026 Sales Guidance from $260.000M-$290.000M to $250.000M-$260.000M vs $267.018M Est
MiMedx Group (NASDAQ:MDXG) lowers FY2026 sales outlook from $260.000 million-$290.000 million to $250.000 million-$260.000 million vs $267.018 million estimate.
10-29 04:13
MiMedx Group Q3 Adj. EPS $(0.01), Inline, Sales $62.283M Miss $68.553M Estimate
MiMedx Group (NASDAQ:MDXG) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 106.67 percent decrease over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $62.280 million which missed the analyst cons...
10-29 04:09
MiMedx Group Inks $25M License Deal With Undisclosed Wound Care Competitor To Settle Allegations Of Infringement Of MiMedx's Patents
MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced that it has entered into a license agreement with a wound care competitor that resolves allegations of infringement of MIMEDX’s patents. Under the terms of the agreement: The licensee will pay MIMEDX a total of $25 million...
10-29 04:03
MIMEDX Announces $25 Million Patent License Agreement
MiMedx Group has entered into a $25 million license agreement with a wound care competitor, resolving patent infringement allegations. The licensee will pay $5 million annually over five years, with the first installment received. MiMedx granted a non-exclusive license to its patents. The agreement highlights the company's strong intellectual property portfolio and innovation in placental biologics. MiMedx will continue to protect its IP while in...
10-28 20:01
MiMedx Group Inc.收跌0.51%，成交额491.28万美元
10月24日，MiMedx Group Inc.（MDXG）收跌0.51%，报3.91美元，成交额491.28万美元，市值5.71亿美元。 行情数据 • 开盘价...
10-24 06:05
MiMedx Group Inc.收跌5.34%，成交额1225.67万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 06:00
MiMedx Group merger delayed amid extended FTC review
MiMedx Group ( ($MDXG) ) has provided an update. MiMedx Group, Inc. and Texas-b...
10-16 21:36
